Cargando…
Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial
Background/Objectives. Vagal block therapy (vBloc) is effective for moderate to severe obesity at one year. Subjects/Methods. The ReCharge trial is a double-blind, randomized controlled clinical trial of 239 participants with body mass index (BMI) of 40 to 45 kg/m or 35 to 40 kg/m with one or more o...
Autores principales: | Shikora, Scott A., Wolfe, Bruce M., Apovian, Caroline M., Anvari, Mehran, Sarwer, David B., Gibbons, Robert D., Ikramuddin, Sayeed, Miller, Christopher J., Knudson, Mark B., Tweden, Katherine S., Sarr, Michael G., Billington, Charles J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515300/ https://www.ncbi.nlm.nih.gov/pubmed/26246907 http://dx.doi.org/10.1155/2015/365604 |
Ejemplares similares
-
Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial
por: Apovian, Caroline M., et al.
Publicado: (2016) -
Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study
por: Morton, John M., et al.
Publicado: (2016) -
Vagal Blocking Improves Glycemic Control and Elevated Blood Pressure in Obese Subjects with Type 2 Diabetes Mellitus
por: Shikora, S., et al.
Publicado: (2013) -
The effect of vagal nerve blockade using electrical impulses on glucose metabolism in nondiabetic subjects
por: Sathananthan, Matheni, et al.
Publicado: (2014) -
Influence of transcutaneous vagus nerve stimulation on cardiac vagal activity: Not different from sham stimulation and no effect of stimulation intensity
por: Borges, Uirassu, et al.
Publicado: (2019)